Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Cytosorbents (CTSO) Interest & Investment Income (2016 - 2026)

Cytosorbents filings provide 15 years of Interest & Investment Income readings, the most recent being -$746000.0 for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 19.55% to -$746000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.6 million, a 86.76% decrease, with the full-year FY2025 number at -$2.6 million, down 86.7% from a year prior.
  • Interest & Investment Income hit -$746000.0 in Q4 2025 for Cytosorbents, down from -$645000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $53748.0 in Q4 2022 to a low of -$746000.0 in Q4 2025.
  • Median Interest & Investment Income over the past 5 years was -$21897.0 (2021), compared with a mean of -$200403.8.
  • Biggest five-year swings in Interest & Investment Income: skyrocketed 337.19% in 2022 and later plummeted 8995.66% in 2025.
  • Cytosorbents' Interest & Investment Income stood at $12294.0 in 2021, then skyrocketed by 337.19% to $53748.0 in 2022, then tumbled by 197.17% to -$52229.0 in 2023, then tumbled by 1094.74% to -$624000.0 in 2024, then decreased by 19.55% to -$746000.0 in 2025.
  • The last three reported values for Interest & Investment Income were -$746000.0 (Q4 2025), -$645000.0 (Q3 2025), and -$616000.0 (Q2 2025) per Business Quant data.